Science’s Shameful Secret
By Victoria Parsons,
Medium
| 04. 28. 2014
Everyday, checking; everyday, hoping. When the acceptance email from the journal finally arrived, a feeling of elation.
“Getting your first paper published in a major journal is a career milestone, and seeing all those months of work in the lab finally in print is so satisfying. But there’s a pressure, too — I had to get this paper published, because my work needs funding.”
It was this pressure that means she won’t let me use her name, for fear of repercussions. For a young evolutionary biologist, research is paid for through grants from a research council. There are seven in the UK, which together fund around three billion pounds of scientific research every year with taxpayer money.
Science is everywhere. From the medicines in our cupboards to the laptop on which this is being written, it is scientific research that drives society forwards. We pay for it with our taxes and it is the gateway for our tomorrows, or at least so we are told. Yet we also rely on science in another way, on a much more fundamental level: we trust...
Related Articles
By Tomoko Otake, The Japan Times | 04.09.2024
A decade ago, researcher Haruko Obokata caused a sensation when she published two papers in the journal Nature, in which she claimed that she had discovered a way to create stem cells easily using the so-called STAP method.
With STAP...
By Yelena Biberman and Jonathan D. Moreno, Bioethics Forum | 04.16.2024
A quiet biological revolution in warfare is underway. The genome is emerging as a new domain of conflict. The level of destruction that only nuclear weapons could previously achieve is fast becoming as accessible as a cyberattack.
Now for the...
CGS is excited to announce the launch of a new anti-eugenics initiative that has been years in the making. Legacies of Eugenics in Science, Medicine, and Technology kicks off with a monthly essay series published at the Los Angeles Review of Books that will expose and contest the reemergence of eugenic ideas in contemporary health sciences, human biotechnology, public health, and medicine. Community and campus-based events featuring the authors are also being planned. The project is a collaboration among CGS...
By Tristan Manalac, BioSpace | 04.02.2024
Verve Therapeutics has suspended enrollment in the Phase Ib Heart-1 study evaluating its lead gene editing program VERVE-101 following a serious adverse event, the company announced Tuesday.
A patient, who received a 0.45-mg/kg dose of VERVE-101, developed a grade 3...